CENBF OTC
CEN Biotech, Inc.
1W: +200.0%
1M: +200.0%
3M: +200.0%
YTD: +200.0%
1Y: +200.0%
3Y: -99.0%
5Y: -100.0%
$0.00
+0.00 (+200.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$336K
+0.0% ▲
Capital Expenditures
$130K
+0.0% ▲
5Y CAGR: -4.2%
Free Cash Flow
-$465K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$191K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$6M | $14M | -$19M | -$2M |
| Depreciation & Amort. | $439K | $443K | $436K | $462K | $489K |
| Stock-Based Comp. | $682K | $1M | $746K | $15M | $553K |
| Change in Working Capital | $71K | $131K | $4M | $842K | -$165K |
| Other Non-Cash Items | $3M | $3M | $1M | $2M | $303K |
| Operating Cash Flow | -$2M | -$869K | -$341K | -$336K | -$336K |
| — Investing Activities — | |||||
| Capital Expenditures | -$5K | $0 | $0 | -$130K | -$130K |
| Acquisitions (Net) | -$100K | -$190K | $2K | $259K | $259K |
| Investment Purchases | $0 | $0 | -$132K | -$120K | $0 |
| Investment Sales | $0 | $0 | $0 | $120K | $0 |
| Other Investing | $0 | $0 | $0 | -$120K | -$120K |
| Investing Cash Flow | -$105K | -$190K | -$130K | $10K | $10K |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | $1M | $469K | $521K | $521K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2M | $1M | $469K | $521K | $521K |
| Net Change in Cash | -$82K | $564 | -$2K | $191K | $191K |
| Cash End of Period | $3K | $4K | $2K | $193K | $193K |
| Free Cash Flow | -$2M | -$869K | -$341K | -$465K | -$465K |